From a translational perspective, utilizing KIF4A expression profiles to develop diagnostic and prognostic models has demonstrated good clinical applicability, and its characteristic pan-cancer upregulation is particularly advantageous for formulating broad-spectrum targeting strategies [4, 5, 9]. The gene discussed is KIF4A; the disease is cancer.